`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`ZTE (USA) INC.,
`Petitioner,
`
`v.
`
`BELL NORTHERN RESEARCH, LLC,
`Patent Owner.
`
`
`
`
`
`
`
`
`PTAB Case No. IPR2019-01365
`Patent No. 7,039,435
`
`
`
`
`
`
`
`
`PETITIONER’S OBJECTIONS TO PATENT OWNER’S EVIDENCE
`UNDER 37 C.F.R. § 42.64(B)(1)
`
`
`
`
`
`
`
`
`
`
`
`Petitioner hereby objects under 37 C.F.R. § 42.64(b)(1) to the following
`
`evidence in Bell Northern Research, LLC’s (“BNR” or “Patent Owner”) Response
`
`(Paper 19) filed on May 12, 2020. As required by Rule 42.64, these objections are
`
`being filed and served within five (5) business days of service of evidence by
`
`Patent Owner on Petitioner.
`
`I.
`
`IDENTIFICATION OF CHALLENGED EVIDENCE AND
`GROUNDS FOR OBJECTIONS
`Exhibit 2022 - Declaration of Mark Horenstein, Ph.D.
`
`A.
`
`Petitioner objects to Exhibit 2022 to the extent that Patent Owner has
`
`violated its duty to disclose relevant information under 37 C.F.R. § 42.51(b)(1)(iii)
`
`that is inconsistent with the positions advanced by its expert, Dr. Horenstein,
`
`concurrent with the filing of its Patent Owner’s Response. Petitioner discovered
`
`that Dr. Horenstein has provided at least sworn testimony in the form of
`
`declarations submitted in support of previous IPR petitions that are inconsistent
`
`with his current declaration and inconsistent with sworn deposition testimony he
`
`gave on January 8, 2020.1 See Ultratec, Inc. v. CaptionCall, LLC, 872 F.3d 1267,
`
`
`1 Dr. Horenstein has provided inconsistent testimony in at least the following
`
`declarations in prior IPR proceedings: IPR2015-01023, Ex. 1022; IPR2015-00609,
`
`Ex. 1008; IPR2015-01928, Ex. 1015; IPR2015-01149, Ex. 1012; IPR2019-01319
`
`Ex. 2053; IPR2019-01320 Ex. 2053.
`
`
`
`- 1 -
`
`
`
`
`
`1272–73 (Fed. Cir. 2017) (finding that inconsistencies in expert testimony bear on
`
`the credibility of the expert in an IPR proceeding).
`
`Petitioner further objects to Exhibit 2022 under Federal Rules of Evidence
`
`rules 403 and 702. Given Dr. Horenstein’s inconsistent testimony, Exhibit 2022 is
`
`unfairly prejudicial, confuses the issues, is misleading, and wastes the Board and
`
`parties’ time. Additionally, based on Dr. Horenstein’s inconsistent testimony,
`
`Exhibit 2022 is not the product of reliable principles and methods, and
`
`Dr. Horenstein has failed to reliably apply principles and methods to the facts of
`
`the case.
`
`B.
`
`Exhibit 2025 - Declaration of Chad Hilyard
`
`Petitioner further objects to Exhibit 2025 under Federal Rules of Evidence
`
`rules 401/402, 403, 602, 802, and 1002. Given Mr. Hilyard’s attempts to provide
`
`testimony for time periods when he was no longer at LSI, and thus for which he
`
`does not have personal knowledge of LSI’s licensing practices or any
`
`considerations as to patent licensing or agreements, Exhibit 2025 includes hearsay
`
`statements, is irrelevant, unfairly prejudicial, confuses the issues, is misleading,
`
`and wastes the Board and parties’ time. Petitioner further objects to Exhibit 2022,
`
`Dr. Horenstein’s declaration, and Paper 19, the Patent Owner’s Response, to the
`
`extent they rely on the impermissible hearsay and irrelevant statements provided in
`
`Mr. Hilyard’s Declaration.
`
`
`
`- 2 -
`
`
`
`
`
`C.
`
`Exhibits 2024, 2027
`
`Petitioner further objects to the form of Exhibits 2024 and 2027, which were
`
`marked AEO and provided in full, instead of in the proper form under PTAB
`
`policies relating to documents for which a Motion to Seal or Protective Order may
`
`be considered applicable. Petitioner notes that at least Exhibits 2024 and 2027 have
`
`been produced in the related district court litigation, in a format that may also serve
`
`useful in this proceeding.
`
`D.
`
`Exhibit 2027
`
`Petitioner further objects to Exhibit 2027 under Federal Rules of Evidence
`
`rules 401/402, 403, and 802. It is not clear what Exhibit 2027 purports to
`
`represent, and Exhibit 2027 not only appears to be a draft document since it
`
`contains mark-ups, but even if taken for the argument for which BNR purports to
`
`provide it, Exhibit 2027 particularly constitutes hearsay information/statements,
`
`and is irrelevant, unfairly prejudicial, confuses the issues, is misleading, and
`
`wastes the Board and parties’ time. Petitioner further objects to Exhibit 2022, Dr.
`
`Horenstein’s declaration, and Paper 19, the Patent Owner’s Response, to the extent
`
`they rely on the impermissible hearsay and irrelevant information/statements
`
`provided in Exhibit 2027.
`
`E.
`
`Exhibit 2028 – “Market Share 4Q17 Update”
`
`Petitioner further objects to Exhibit 2028 under Federal Rules of Evidence
`
`
`
`- 3 -
`
`
`
`
`
`rules 401/402, 403, 802, and 1002. It is not clear what Exhibit 2028 purports to
`
`represent, but even if taken for the arguments for which BNR purports to provide
`
`it, Exhibit 2028 then particularly constitutes hearsay information/statements, and
`
`is irrelevant, unfairly prejudicial, confuses the issues, is misleading, and wastes the
`
`Board and parties’ time. Petitioner further objects to Exhibit 2022, Dr.
`
`Horenstein’s declaration, and Paper 19, the Patent Owner’s Response, to the extent
`
`they rely on the impermissible hearsay and irrelevant information/statements
`
`provided in Exhibit 2028.
`
`II. Conclusion
`
`To the extent that Patent Owner fails to correct the defects identified above,
`
`Petitioner reserves the right to file a Motion to Exclude under 37 C.F.R. § 42.64(c).
`
`
`
`
`
`
`
`- 4 -
`
`
`
`Dated: May 19, 2020
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`/Amol A. Parikh/
`Amol A. Parikh
`USPTO Reg. No. 60,671
`MCDERMOTT WILL & EMERY LLP
`444 West Lake Street, Suite 4000
`Chicago, IL 60606
`Phone: 312-984-6477
`Fax: 312-984-7700
`amparikh@mwe.com
`jrbaker@mwe.com
`
`Charles McMahon
`USPTO Reg. No. 44,926
`MCDERMOTT WILL & EMERY LLP
`444 West Lake Street, Suite 4000
`Chicago, Illinois 60606
`Phone: 312-984-7641
`Fax: 312-984-7700
`cmcmahon@mwe.com
`
`Thomas M. DaMario
`USPTO Reg. No. 77,142
`MCDERMOTT WILL & EMERY LLP
`444 West Lake Street, Suite 4000
`Chicago, Illinois 60606
`Phone: 312-984-7527
`Fax: 312-984-7700
`tdamario@mwe.com
`
`Jiaxiao Zhang
`USPTO Reg. No. 63,235
`MCDERMOTT WILL & EMERY LLP
`18565 Jamboree Road, Suite 250
`Irvine, California 92612
`Phone: 949-757-6398
`Fax: 949-851-9348
`jiazhang@mwe.com
`
`
`
`- 5 -
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a true copy of the foregoing
`
`PETITIONER’S OBJECTIONS TO PATENT OWNER’S EVIDENCE was
`
`served in its entirety this 19th day of May 2020, by electronic mail on the Patent
`
`Owner via its attorneys of record:
`
`SKIERMONT DERBY LLP
`Steven W. Hartsell
`Alexander E. Gasser
`Paul J. Skiermont
`Sadaf R. Abdullah
`Mieke K. Malmberg
`BNR_SDTeam@skiermontderby.com
`
`
`Dated: May 19, 2020
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Amol A. Parikh/
`Lead Counsel
`Amol A. Parikh
`USPTO Reg. No. 60,671
`MCDERMOTT WILL & EMERY LLP
`444 West Lake Street, Suite 4000
`Chicago, IL 606060-0029
`Phone: 312-984-6477
`Fax: 312-984-7700
`amparikh@mwe.com
`
`- 6 -
`
`
`
`
`
`
`
`